Xintela
xintela.se
Actively hiring
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Xintelas forskning och utveckling inom stamcellsterapi banar ny väg för behandling av svåra sjukdomar som artros och svårläkta sår.
News
Report
Report
Xintela AB: Last patient dosed in Xintela's clinical study on difficult-to-heal leg ulcers
Xintela (XINT) announces that the last patient has been dosed in the company's clinical Phase I/IIa study with XSTEM in patients with difficult-to-heal venous leg ulcers. XSTEM, which consists of allogeneic
Read more
Report
Xintela AB: Xintela's stem cell product XSTEM shows safety and sustained positive efficacy results two years after treatment in knee osteoarthritis clinical study
The final analysis including the 24-month evaluation of Xintela's (XINT) clinical study on XSTEM for knee osteoarthritis has now been completed. The results show continued safety, reduction of knee pain
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Lund
Sweden
HQ
Medicon Village / Scheeletorget 1, Lund, Skåne, 223 81, SE